138 related articles for article (PubMed ID: 36640858)
1. Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application.
Wu Q; Chen P; Li J; Lin Z; Zhang Q; Kwok HF
Pharmacol Res; 2023 Feb; 188():106654. PubMed ID: 36640858
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
Qu M; Li J; Yuan L
Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
[TBL] [Abstract][Full Text] [Related]
3. Homoharringtonine inhibits fibroblasts proliferation, extracellular matrix production and reduces surgery-induced knee arthrofibrosis via PI3K/AKT/mTOR pathway-mediated apoptosis.
Sun Y; Dai J; Jiao R; Jiang Q; Wang J
J Orthop Surg Res; 2021 Jan; 16(1):9. PubMed ID: 33407698
[TBL] [Abstract][Full Text] [Related]
4. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways.
Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y
Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine inhibits the progression of hepatocellular carcinoma by suppressing the PI3K/AKT/GSK3β/Slug signaling pathway.
Liu HY; Dong TX; Li ZZ; Li TT; Jiang J; Zhu MW; An TT; Chen YD; Yang XH
Neoplasma; 2021 Sep; 68(5):924-937. PubMed ID: 33998239
[TBL] [Abstract][Full Text] [Related]
6. Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2/M cell cycle arrest.
Tang JF; Li GL; Zhang T; Du YM; Huang SY; Ran JH; Li J; Chen DL
Arch Biochem Biophys; 2021 Mar; 700():108774. PubMed ID: 33548212
[TBL] [Abstract][Full Text] [Related]
7. Repurposing homoharringtonine for thyroid cancer treatment through TIMP1/FAK/PI3K/AKT signaling pathway.
Xi C; Zhang G; Sun N; Liu M; Ju N; Shen C; Song H; Luo Q; Qiu Z
iScience; 2024 Jun; 27(6):109829. PubMed ID: 38770133
[TBL] [Abstract][Full Text] [Related]
8. Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p/AKT/mTOR signaling pathway.
Wang LB; Wang DN; Wu LG; Cao J; Tian JH; Liu R; Ma R; Yu JJ; Wang J; Huang Q; Xiong WY; Zhang X
Int J Biol Sci; 2021; 17(4):995-1009. PubMed ID: 33867824
[TBL] [Abstract][Full Text] [Related]
9. NKD1 targeting PCM1 regulates the therapeutic effects of homoharringtonine on colorectal cancer.
Cao J; Tao X; Shi B; Wang J; Ma R; Zhao J; Tian J; Huang Q; Yu J; Wang L
Mol Biol Rep; 2023 Aug; 50(8):6543-6556. PubMed ID: 37338734
[TBL] [Abstract][Full Text] [Related]
10. Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia.
Wei W; Huang S; Ling Q; Mao S; Qian Y; Ye W; Li F; Pan J; Lin X; Huang J; Huang X; Zhai Y; Sun J; Jin J
J Transl Med; 2022 Jul; 20(1):299. PubMed ID: 35794605
[TBL] [Abstract][Full Text] [Related]
11. Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine.
Howard TP; Oberlick EM; Rees MG; Arnoff TE; Pham MT; Brenan L; DoCarmo M; Hong AL; Kugener G; Chou HC; Drosos Y; Mathias KM; Ramos P; Seashore-Ludlow B; Giacomelli AO; Wang X; Freeman BB; Blankenship K; Hoffmann L; Tiv HL; Gokhale PC; Johannessen CM; Stewart EA; Schreiber SL; Hahn WC; Roberts CWM
Clin Cancer Res; 2020 Sep; 26(18):4995-5006. PubMed ID: 32631955
[TBL] [Abstract][Full Text] [Related]
12. [Blockage of mTOR signaling pathway by homoharringtonine inhibits proliferation and induces apoptosis of HT29 human colorectal tumor cells].
Wang D; Tao W; Zhang X; You P; Mu X; Cao J; Li X; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Apr; 34(4):346-353. PubMed ID: 29973326
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft.
Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H
Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644
[TBL] [Abstract][Full Text] [Related]
14. Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway.
Wang H; Wang R; Huang D; Li S; Gao B; Kang Z; Tang B; Xie J; Yan F; Liang R; Li H; Yan J
Front Pharmacol; 2021; 12():592071. PubMed ID: 33716735
[TBL] [Abstract][Full Text] [Related]
15. Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway.
Li S; Bo Z; Jiang Y; Song X; Wang C; Tong Y
Oncol Rep; 2020 Jan; 43(1):113-120. PubMed ID: 31789418
[TBL] [Abstract][Full Text] [Related]
16. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.
Guo S; Bai X; Shi S; Deng Y; Kang X; An H
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681590
[TBL] [Abstract][Full Text] [Related]
17. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
18. Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma.
Chen C; Wu J; Hicks C; Lan MS
Cell Signal; 2023 Sep; 109():110753. PubMed ID: 37301315
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Triptolide Combined with Homoharringtonine on Proliferation and Apoptosis of KG-1α Cells].
Li X; Liu JY; Yuan XH; Lin ZX; Wu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):347-353. PubMed ID: 29665897
[TBL] [Abstract][Full Text] [Related]
20. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
